A systematic review and economic model of the effectiveness and ...
A systematic review and economic model of the effectiveness and ...
A systematic review and economic model of the effectiveness and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
32 TABLE 7<br />
Clinical <strong>effectiveness</strong><br />
MPH high dose (>30 mg/day) versus placebo<br />
Study Design Intervention – N Age Duration Core outcomes<br />
(years) (weeks)<br />
Administered two or more times daily<br />
Gittelman-Klein, 197657 P MPH (max. 60 mg/day, b.d.) – 166 6–12 12 Core: no core symptoms reported<br />
QoL: not reported<br />
AE: side effects st<strong>and</strong>ardised form: severity <strong>and</strong> consistency<br />
C (2×) MPH (25–40 mg/day, t.d.s.) – 19 12–19 6 Core: no hyp; Abbreviated Conners’ Questionnaire<br />
QoL: no CGI; Loney <strong>and</strong> Ordona Scale: response (patients <strong>and</strong> parents)<br />
AE: STESS (based on interview with parent <strong>and</strong> patient)<br />
Klorman, 1987 66<br />
Brown, 198843 C (4×) MPH (42.56 mg/day, b.d.) –11 13–15 8 Core: CPRS: Hyperactivity Index; Conners’ Teacher Hyperactivity Index;<br />
ACTeRS: hyperactivity<br />
QoL: not reported<br />
AE: SERS (parents); weight<br />
Barkley, 199039 C (3×) MPH (1.0 mg/kg/day, b.d.) – 83 5–13 3 Core: not reported<br />
QoL: not reported<br />
AE: Stimulant Drug Side Effects Questionnaire: 17-item list<br />
Klorman, 199067 C (2×) MPH (35.21 mg/day, t.d.) – 48 12–18 6 Core: Abbreviated Conners’ Hyperactivity Questionnaire (parents,<br />
teachers); IOWA inattention/overactivity scale (parents, teachers);<br />
TOTS: hyperactivity <strong>and</strong> attention scales (parents, teachers)<br />
QoL: no CGI; ratings <strong>of</strong> global outcome (parents/patients)<br />
AE: STESS (patients, parents); Nowlis Mood Scale: fatigue (patients);<br />
weight<br />
Pelham, 199379 C (3×) MPH (32 mg/day, b.d.) – 31 5.4–9.9 6 Core: no hyp; IOWA CTRS: inattention/overactivity<br />
QoL: not reported<br />
AE: not reported<br />
Ahmann, 199335 C (3×) MPH (1.5 mg/kg/day, t.d.) – 234 5–15 4 Core: not reported<br />
QoL: not reported<br />
AE: BSEQ<br />
C (4×) MPH (1.2 mg/kg/day, b.d.) – 22 7–13 6 Core: no hyp; IOWA CTRS: inattention/overactivity<br />
QoL: not reported<br />
Kolko, 1999 69<br />
AE: SSERS<br />
P MPH (15, 30 or 45 mg/day, t.d.) – 312 6–12 4 Core: SNAP-IV Hyperactivity/Impulsivity (teacher rated) (parent rated)<br />
QoL: CGI (investigator rated)<br />
AE: solicited <strong>and</strong> spontaneous reports: focus on sleep quality, tics <strong>and</strong><br />
appetite (parent)<br />
Wolraich, 2001 97<br />
Quinn, 2003 84 [Confidential information removed]<br />
ACTeRS, ADD-H Comprehensive Teachers’ Rating Scale; b.d., twice daily; BSEQ, Barkley Side Effects Questionnaire; C, crossover trial (number <strong>of</strong> crossovers); CGI, Clinical Global<br />
Impression; CPRS, Conners’ Parent Rating Scale; CTRS, Conners’ Teacher Rating Scale; P, parallel trial; SNAP, Swanson, Nolan <strong>and</strong> Pelham (scale); SSERS, Stimulant Drug Side Effects<br />
Rating Scale; t.d.s., three times daily.